289 related articles for article (PubMed ID: 33060414)
1. The Efficacy of Atropine Combined With Orthokeratology in Slowing Axial Elongation of Myopia Children: A Meta-Analysis.
Gao C; Wan S; Zhang Y; Han J
Eye Contact Lens; 2021 Feb; 47(2):98-103. PubMed ID: 33060414
[TBL] [Abstract][Full Text] [Related]
2. The efficacy and safety of 0.01% atropine alone or combined with orthokeratology for children with myopia: A meta-analysis.
Wang Z; Wang P; Jiang B; Meng Y; Qie S; Yan Z
PLoS One; 2023; 18(7):e0282286. PubMed ID: 37494360
[TBL] [Abstract][Full Text] [Related]
3. The effect of 0.01% atropine and orthokeratology on ocular axial elongation for myopia children: A meta-analysis (a PRISMA-compliant article).
Yu Y; Liu J
Medicine (Baltimore); 2022 May; 101(18):e29191. PubMed ID: 35550467
[TBL] [Abstract][Full Text] [Related]
4. Combined Orthokeratology with Atropine for Children with Myopia: A Meta-Analysis.
Wang S; Wang J; Wang N
Ophthalmic Res; 2021; 64(5):723-731. PubMed ID: 32781450
[TBL] [Abstract][Full Text] [Related]
5. Orthokeratology for Slowing Myopia Progression in Children: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Tang K; Si J; Wang X; Lu X; Bi H
Eye Contact Lens; 2023 Sep; 49(9):404-410. PubMed ID: 37284749
[TBL] [Abstract][Full Text] [Related]
6. Low concentration atropine combined with orthokeratology in the treatment of axial elongation in children with myopia: A meta-analysis.
Yang N; Bai J; Liu L
Eur J Ophthalmol; 2022 Jan; 32(1):221-228. PubMed ID: 33678055
[TBL] [Abstract][Full Text] [Related]
7. Efficacy, Safety and Acceptability of Orthokeratology on Slowing Axial Elongation in Myopic Children by Meta-Analysis.
Li SM; Kang MT; Wu SS; Liu LR; Li H; Chen Z; Wang N
Curr Eye Res; 2016 May; 41(5):600-8. PubMed ID: 26237276
[TBL] [Abstract][Full Text] [Related]
8. The effect of 0.01% atropine on ocular axial elongation for myopia children: A protocol for systematic review and meta-analysis.
Gao Y; Yu Y
Medicine (Baltimore); 2022 Jun; 101(22):e29409. PubMed ID: 35665735
[TBL] [Abstract][Full Text] [Related]
9. Additive effects of orthokeratology and atropine 0.01% ophthalmic solution in slowing axial elongation in children with myopia: first year results.
Kinoshita N; Konno Y; Hamada N; Kanda Y; Shimmura-Tomita M; Kakehashi A
Jpn J Ophthalmol; 2018 Sep; 62(5):544-553. PubMed ID: 29974278
[TBL] [Abstract][Full Text] [Related]
10. Adjunctive effects of orthokeratology and atropine 0.01% eye drops on slowing the progression of myopia.
Zhou H; Zhao G; Li Y
Clin Exp Optom; 2022 Jul; 105(5):520-526. PubMed ID: 34228946
[TBL] [Abstract][Full Text] [Related]
11. Higher order aberrations and axial elongation in combined 0.01% atropine with orthokeratology for myopia control.
Vincent SJ; Tan Q; Ng ALK; Cheng GPM; Woo VCP; Cho P
Ophthalmic Physiol Opt; 2020 Nov; 40(6):728-737. PubMed ID: 32888318
[TBL] [Abstract][Full Text] [Related]
12. Interventions to slow progression of myopia in children.
Walline JJ; Lindsley KB; Vedula SS; Cotter SA; Mutti DO; Ng SM; Twelker JD
Cochrane Database Syst Rev; 2020 Jan; 1(1):CD004916. PubMed ID: 31930781
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of the Euclid orthokeratology lens in slowing axial elongation.
Bullimore MA; Liu M
Cont Lens Anterior Eye; 2023 Oct; 46(5):101875. PubMed ID: 37365049
[TBL] [Abstract][Full Text] [Related]
14. Combination of orthokeratology lens with 0.01% atropine in slowing axial elongation in children with myopia: a randomized double-blinded clinical trial.
Yu S; Du L; Ji N; Li B; Pang X; Li X; Ma N; Huang C; Fu A
BMC Ophthalmol; 2022 Nov; 22(1):438. PubMed ID: 36380280
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Administration of 0.02% Atropine and Orthokeratology for Myopia Control.
Lyu Y; Ji N; Fu AC; Wang WQ; Wei L; Qin J; Zhao BX
Eye Contact Lens; 2021 Feb; 47(2):81-85. PubMed ID: 32443010
[TBL] [Abstract][Full Text] [Related]
16. The synergistic efficacy and safety of combined low-concentration atropine and orthokeratology for slowing the progression of myopia: A meta-analysis.
Zheng NN; Tan KW
Ophthalmic Physiol Opt; 2022 Nov; 42(6):1214-1226. PubMed ID: 35919929
[TBL] [Abstract][Full Text] [Related]
17. Difference in the effect of orthokeratology on slowing teen myopia with different years of follow-up.
Meng Z; Shuo G; Guohu D; Wei Z; Jingyi L; Yuanchao C; Zhaodong L; Changhong Y
J Fr Ophtalmol; 2022 Sep; 45(7):718-727. PubMed ID: 35577700
[TBL] [Abstract][Full Text] [Related]
18. Adjunctive effect of orthokeratology and low dose atropine on axial elongation in fast-progressing myopic children-A preliminary retrospective study.
Chen Z; Huang S; Zhou J; Xiaomei Q; Zhou X; Xue F
Cont Lens Anterior Eye; 2019 Aug; 42(4):439-442. PubMed ID: 30482510
[TBL] [Abstract][Full Text] [Related]
19. Combined 0.01% atropine with orthokeratology in childhood myopia control (AOK) study: A 2-year randomized clinical trial.
Tan Q; Ng AL; Cheng GP; Woo VC; Cho P
Cont Lens Anterior Eye; 2023 Feb; 46(1):101723. PubMed ID: 35654683
[TBL] [Abstract][Full Text] [Related]
20. One-year results of 0.01% atropine with orthokeratology (AOK) study: a randomised clinical trial.
Tan Q; Ng AL; Choy BN; Cheng GP; Woo VC; Cho P
Ophthalmic Physiol Opt; 2020 Sep; 40(5):557-566. PubMed ID: 32776533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
